2025 annual financial data
Processa Pharmaceuticals 2025 Operating margin
Processa Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,988,505 USD and net income was -13,563,834 USD.
Operating cash flow was -11,385,195 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,988,505 USD
- Net income
- -13,563,834 USD
- Operating cash flow
- -11,385,195 USD